SLGL: Sol-Gel Technologies Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 20.39
Enterprise Value ($M) 6.97
Book Value ($M) 34.70
Book Value / Share 1.25
Price / Book 0.59
NCAV ($M) 29.68
NCAV / Share 1.07
Price / NCAV 0.69

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 5.81
Current Ratio 5.81

Balance Sheet (mrq) ($M)
Current Assets 37.95
Assets 42.98
Liabilities 8.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Phoenix Holdings Ltd. 8.87 -4.07
11-14 13G/A Armistice Capital, Llc 4.99 -31.47
04-08 13D/A Arkin Moshe 60.80
2024-01-31 13G Migdal Insurance & Financial Holdings Ltd. 5.31 -0.25

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 18,830 45,390 41.48
2025-02-03 30,248 88,258 34.27
2025-01-31 32,816 63,540 51.65
2025-01-30 9,255 77,433 11.95

(click for more detail)

Similar Companies
SGMO – Sangamo Therapeutics, Inc. SHPH – Shuttle Pharmaceuticals Holdings, Inc.
SILO – Silo Pharma, Inc. SLRX – Salarius Pharmaceuticals, Inc.
SLS – SELLAS Life Sciences Group, Inc.


Financial data and stock pages provided by
Fintel.io